Study Evaluating Etanercept 25mg or 50mg Administered Subcutaneously to Healthy Chinese Male Subjects
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to assess the pharmacokinetics of etanercept in healthy
Chinese male subjects. Safety and tolerability data will also be obtained.